TrialHematological oncology2021

Humanized anti-CD19 chimeric antigen receptor-T cell therapy is safe and effective in lymphoma and leukemia patients with chronic and resolved hepatitis B virus infection.

Rui Cui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.